AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
THE ROLE OF INTENSIVE AML-SPECIFIC THERAPY IN TREATMENT OF CHILDREN WITH RAEB AND RAEB-T
Authors: CREUTZIG U BENDERGOTZE C RITTER J ZIMMERMANN M STOLLMANNGIBBELS B KORHOLZ D NIEMEYER C
Citation: U. Creutzig et al., THE ROLE OF INTENSIVE AML-SPECIFIC THERAPY IN TREATMENT OF CHILDREN WITH RAEB AND RAEB-T, Leukemia, 12(5), 1998, pp. 652-659
DURATION OF FIRST REMISSION PREDICTS REMISSION RATES AND LONG-TERM SURVIVAL IN CHILDREN WITH RELAPSED ACUTE MYELOGENOUS LEUKEMIA
Authors: STAHNKE K BOOS J BENDERGOTZE C RITTER J ZIMMERMANN M CREUTZIG U
Citation: K. Stahnke et al., DURATION OF FIRST REMISSION PREDICTS REMISSION RATES AND LONG-TERM SURVIVAL IN CHILDREN WITH RELAPSED ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 12(10), 1998, pp. 1534-1538
SPONTANEOUS REMISSION IN NEONATES WITH DOWNS-SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA - TRANSIENT MYELOPROLIFERATIVE DISEASE
Authors: CREUTZIG U BAUMANN M
Citation: U. Creutzig et M. Baumann, SPONTANEOUS REMISSION IN NEONATES WITH DOWNS-SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA - TRANSIENT MYELOPROLIFERATIVE DISEASE, Onkologie, 21(3), 1998, pp. 184-188
PROGNOSIS OF CHILDREN WITH FIRST RELAPSE OF AML
Authors: CREUTZIG U RITTER J BOOS J ZIMMERMANN M BENDERGOTZE C STAHNKE K
Citation: U. Creutzig et al., PROGNOSIS OF CHILDREN WITH FIRST RELAPSE OF AML, Klinische Padiatrie, 210(4), 1998, pp. 207-211
5 CHILDREN AND 7 ADULTS WITH CD7- ACUTE NATURAL-KILLER-CELL LEUKEMIA(CD56+ CD3)
Authors: SPAHN G SPERLING C BUCHNER T CREUTZIG U SCHLEGELBERGER B HARBOTT J DOHNER H DORKEN B LUDWIG WD
Citation: G. Spahn et al., 5 CHILDREN AND 7 ADULTS WITH CD7- ACUTE NATURAL-KILLER-CELL LEUKEMIA(CD56+ CD3), British Journal of Haematology, 102(1), 1998, pp. 114-114
FAVORABLE DRUG-RESISTANCE PROFILES IN CHILDREN WITH DOWNS-SYNDROME (DS) AND ACUTE-LEUKEMIA
Authors: ZWAAN CM RAMAKERSVANWOERDEN NL KASPERS GJL PIETERS R WUNSCHE R ROTTIER MMA HAHLEN K JANKASCHAUB G CREUTZIG U VEERMAN AJP
Citation: Cm. Zwaan et al., FAVORABLE DRUG-RESISTANCE PROFILES IN CHILDREN WITH DOWNS-SYNDROME (DS) AND ACUTE-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 226-227
RELATIONSHIP BETWEEN MAJOR VAULT PROTEIN LUNG RESISTANCE PROTEIN, MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN, P-GLYCOPROTEIN EXPRESSION, AND DRUG-RESISTANCE IN CHILDHOOD LEUKEMIA
Authors: DENBOER ML PIETERS R KAZEMIER KM ROTTIER MMA ZWAAN CM KASPERS GJL JANKASCHAUB G HENZE G CREUTZIG U SCHEPER RJ VEERMAN AJP
Citation: Ml. Denboer et al., RELATIONSHIP BETWEEN MAJOR VAULT PROTEIN LUNG RESISTANCE PROTEIN, MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN, P-GLYCOPROTEIN EXPRESSION, AND DRUG-RESISTANCE IN CHILDHOOD LEUKEMIA, Blood, 91(6), 1998, pp. 2092-2098
LOW-RISK OF SECONDARY LEUKEMIAS AFTER CHEMOTHERAPY WITHOUT MECHLORETHAMINE IN CHILDHOOD HODGKINS-DISEASE
Authors: SCHELLONG G RIEPENHAUSEN M CREUTZIG U RITTER J HARBOTT J MANN G GADNER H
Citation: G. Schellong et al., LOW-RISK OF SECONDARY LEUKEMIAS AFTER CHEMOTHERAPY WITHOUT MECHLORETHAMINE IN CHILDHOOD HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2247-2253
COMPARISON OF EQUIPOTENTIAL DOSES OF DAUNORUBICIN AND IDARUBICIN DURING INDUCTION - FIRST RESULTS OF THE RANDOMIZED TRIAL BFM-93 IN CHILDREN WITH AML
Authors: CREUTZIG U HERMANN J GADNER H ZIMMERMANN M JURGENS H RITTER J
Citation: U. Creutzig et al., COMPARISON OF EQUIPOTENTIAL DOSES OF DAUNORUBICIN AND IDARUBICIN DURING INDUCTION - FIRST RESULTS OF THE RANDOMIZED TRIAL BFM-93 IN CHILDREN WITH AML, Blood, 90(10), 1997, pp. 2597-2597
CHRONIC MYELOMONOCYTIC LEUKEMIA IN CHILDHOOD - A RETROSPECTIVE ANALYSIS OF 110 CASES
Authors: NIEMEYER CM ARICO M BASSO G BIONDI A RAJNOLDI AC CREUTZIG U HAAS O HARBOTT J HASLE H KERNDRUP G LOCATELLI F MANN G STOLLMANNGIBBELS B VANTVEERKORTHOF ET VANWERING E ZIMMERMANN M
Citation: Cm. Niemeyer et al., CHRONIC MYELOMONOCYTIC LEUKEMIA IN CHILDHOOD - A RETROSPECTIVE ANALYSIS OF 110 CASES, Blood, 89(10), 1997, pp. 3534-3543
DIAGNOSIS AND TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN CHILDHOOD
Authors: CREUTZIG U
Citation: U. Creutzig, DIAGNOSIS AND TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN CHILDHOOD, Critical reviews in oncology/hematology, 22(3), 1996, pp. 183-196
THERAPY OF CHILDHOOD ACUTE MYELOGENOUS LEUKEMIAS
Authors: VORMOOR J BOOS J STAHNKE K JURGENS H RITTER J CREUTZIG U
Citation: J. Vormoor et al., THERAPY OF CHILDHOOD ACUTE MYELOGENOUS LEUKEMIAS, Annals of hematology, 73(1), 1996, pp. 11-24
MYELODYSPLASIA AND ACUTE MYELOGENOUS LEUKEMIA IN DOWNS-SYNDROME - A REPORT OF 40 CHILDREN OF THE AML-BFM STUDY-GROUP
Authors: CREUTZIG U RITTER J VORMOOR J LUDWIG WD NIEMEYER C REINISCH I STOLLMANNGIBBELS B ZIMMERMANN M HARBOTT J
Citation: U. Creutzig et al., MYELODYSPLASIA AND ACUTE MYELOGENOUS LEUKEMIA IN DOWNS-SYNDROME - A REPORT OF 40 CHILDREN OF THE AML-BFM STUDY-GROUP, Leukemia, 10(11), 1996, pp. 1677-1686
PROGNOSIS IN CHILDREN WITH CHRONIC MYELOG ENOUS LEUKEMIA - A RETROSPECTIVE ANALYSIS OF 75 PATIENTS
Authors: CREUTZIG U RITTER J ZIMMERMANN M KLINGEBIEL T
Citation: U. Creutzig et al., PROGNOSIS IN CHILDREN WITH CHRONIC MYELOG ENOUS LEUKEMIA - A RETROSPECTIVE ANALYSIS OF 75 PATIENTS, Klinische Padiatrie, 208(4), 1996, pp. 236-241
TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN CHILDHOOD - PROPOSAL FOR A MULTICENTER PILOT PROTOCOL CML-PAD
Authors: SUTTORP M LION T CREUTZIG U KLINGEBIEL T GADNER H
Citation: M. Suttorp et al., TREATMENT OF CHRONIC MYELOID-LEUKEMIA IN CHILDHOOD - PROPOSAL FOR A MULTICENTER PILOT PROTOCOL CML-PAD, Klinische Padiatrie, 208(4), 1996, pp. 242-249
INTRACELLULAR RETENTION OF CYTOSINE-ARABINOSIDE TRIPHOSPHATE IN BLASTCELLS FROM CHILDREN WITH ACUTE MYELOGENOUS AND LYMPHOBLASTIC-LEUKEMIA
Authors: BOOS J HOHENLOCHTER B SCHULZEWESTHOFF P SCHILLER M ZIMMERMANN M CREUTZIG U RITTER J JURGENS H
Citation: J. Boos et al., INTRACELLULAR RETENTION OF CYTOSINE-ARABINOSIDE TRIPHOSPHATE IN BLASTCELLS FROM CHILDREN WITH ACUTE MYELOGENOUS AND LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 26(6), 1996, pp. 397-404
ACUTE-LEUKEMIA IN CHILDREN - CLASSIFICATI ON, DIAGNOSIS, TREATMENT, PROGNOSIS
Authors: CREUTZIG U SCHRAPPE M
Citation: U. Creutzig et M. Schrappe, ACUTE-LEUKEMIA IN CHILDREN - CLASSIFICATI ON, DIAGNOSIS, TREATMENT, PROGNOSIS, Der Internist, 37(10), 1996, pp. 982-993
MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) ASSOCIATED WITH COMPLETE OR PARTIAL MONOSOMY 7 - AN EWOG-MDS STUDY OF 111 CHILDREN
Authors: HASLE H ARICO M BASSO G BIONDI A RAJNOLDI AC CREUTZIG U FENU S FONATSCH C HAAS OA HARBOTT J KERNDRUP G MANN G MIHAL V NIEMEYER CM PTOSZKOVA H RITTER J SLATER R STARY J STOLLMANN B TESTI A VANWERING ER ZIMMERMANN M
Citation: H. Hasle et al., MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) ASSOCIATED WITH COMPLETE OR PARTIAL MONOSOMY 7 - AN EWOG-MDS STUDY OF 111 CHILDREN, Blood, 88(10), 1996, pp. 2325-2325
CLINICAL, MORPHOLOGIC, CYTOGENETIC AND PROGNOSTIC IMPLICATIONS OF CD34 EXPRESSION IN CHILDHOOD AND ADULT DE-NOVO AML
Authors: SPERLING C BUCHNER T CREUTZIG U RITTER J HARBOTT J FONATSCH C SAUERLAND C MIELCAREK M MASCHMEYER G LOFFLER H LUDWIG WD
Citation: C. Sperling et al., CLINICAL, MORPHOLOGIC, CYTOGENETIC AND PROGNOSTIC IMPLICATIONS OF CD34 EXPRESSION IN CHILDHOOD AND ADULT DE-NOVO AML, Leukemia & lymphoma, 17(5-6), 1995, pp. 417-426
IN-VITRO CHEMOSENSITIVITY ASSESSED WITH THE MTT ASSAY IN CHILDHOOD ACUTE NONLYMPHOBLASTIC LEUKEMIA
Authors: KLUMPER E PIETERS R KASPERS GJL HUISMANS DR LOONEN AH ROTTIER MMA VANWERING ER VANDERDOESVANDENBERG A HAHLEN K CREUTZIG U VEERMAN AJP
Citation: E. Klumper et al., IN-VITRO CHEMOSENSITIVITY ASSESSED WITH THE MTT ASSAY IN CHILDHOOD ACUTE NONLYMPHOBLASTIC LEUKEMIA, Leukemia, 9(11), 1995, pp. 1864-1869
EARLY DIAGNOSIS OF NEOPLASTIC DISEASES IN CHILDHOOD
Authors: CREUTZIG U GRAF N
Citation: U. Creutzig et N. Graf, EARLY DIAGNOSIS OF NEOPLASTIC DISEASES IN CHILDHOOD, Onkologie, 18, 1995, pp. 24-27
ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN WI TH DOWNS-SYNDROME
Authors: CREUTZIG U
Citation: U. Creutzig, ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN WI TH DOWNS-SYNDROME, Klinische Padiatrie, 207(4), 1995, pp. 136-144
12Q13, A NEW RECURRENT BREAKPOINT IN ACUTE NONLYMPHOBLASTIC LEUKEMIA
Authors: SEYGER MMB RITTERBACH J CREUTZIG U GNEKOW AK GOBEL U GRAF N REITER A LAMPERT F HARBOTT J
Citation: Mmb. Seyger et al., 12Q13, A NEW RECURRENT BREAKPOINT IN ACUTE NONLYMPHOBLASTIC LEUKEMIA, Cancer genetics and cytogenetics, 80(1), 1995, pp. 23-28
BONE-MARROW TRANSPLANTATION
Authors: CREUTZIG U RITTER J ZIMMERMANN M BENDERGOTZE C SCHELLONG G
Citation: U. Creutzig et al., BONE-MARROW TRANSPLANTATION, Lancet, 346(8966), 1995, pp. 60-60
CLINICAL-SIGNIFICANCE OF SURFACE-ANTIGEN EXPRESSION IN CHILDREN WITH ACUTE MYELOID-LEUKEMIA - RESULTS OF STUDY AML-BFM-87
Authors: CREUTZIG U HARBOTT J SPERLING C RITTER J ZIMMERMANN M LOFFLER H RIEHM H SCHELLONG G LUDWIG WD
Citation: U. Creutzig et al., CLINICAL-SIGNIFICANCE OF SURFACE-ANTIGEN EXPRESSION IN CHILDREN WITH ACUTE MYELOID-LEUKEMIA - RESULTS OF STUDY AML-BFM-87, Blood, 86(8), 1995, pp. 3097-3108
Risultati: 1-25 | 26-35